NPR reports New Ebola Drug 100 Percent Effective In Monkeys
"The drug that Geisbert's team devised, in collaboration with a British Columbia biotech company called Tekmira Pharmaceuticals, is a departure from other anti-Ebola measures. It contains snippets of RNA derived from three of the virus' seven genes. That 'payload' is packaged in protective packets of nucleic acid and fat molecules. These little stealth missiles attach to the Ebola virus' replication machinery, 'silencing' the genes from which they were derived. That prevents the virus from making more viruses."
No comments:
Post a Comment